Compare Pinterest Inc (PINS) vs TG Therapeutics Inc (TGTX) Price & Performance

Pinterest (PINS) trades at $20.525, up 1.06% with a bullish technical signal despite mixed oscillators. The company demonstrates strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with consistent earnings beats in recent quarters. Analyst consensus is strongly positive with 54% buy ratings and a $27.93 price target, representing 36% upside potential from current levels.

PINS offers compelling growth potential driven by international monetization and visual search advertising innovations, though elevated valuation metrics (P/E 60.38) and insider selling activity warrant caution. The stock's primary catalysts include continued user growth and advertising revenue expansion, while risks center on competitive pressure and execution challenges in global markets.

TG Therapeutics (TGTX) trades at $55.37, up 4.57% today, but faces a bearish technical signal with recent earnings misses. Strong revenue growth is driven by BRIUMVI, with 2026 guidance raised to $950 million, though profitability is pressured by investments. A shareholder investigation and volatile cash flows add uncertainty, while analyst consensus remains bullish with an $80.50 price target.

The outlook hinges on BRIUMVI's market share gains and subcutaneous formulation progress, offering upside if execution succeeds. Risks include the fiduciary investigation, competitive pressures, and reliance on a single product. The stock presents a high-risk, high-reward opportunity, with current valuation reflecting growth expectations but vulnerable to setbacks.